Soluna Holdings, Inc. (“Soluna” or the “Company”), (NASDAQ: SLNH), a developer of green data centers for intensive computing applications including Bitcoin mining and AI, announced an open letter to shareholders from Soluna Holdings CEO, John Belizaire.

Service providers in the USA and its territories can now expand outdoor gigabit service with technology proven in more than 130 networks HOFFMAN ESTATES, Ill., May 21, 2024 /PRNewswire/ -- Cambium Networks (NASDAQ: CMBM), a leading global provider of networking solutions, today announced that service providers, enterprises, and industrial network operators in the USA and territories as well as Canada are now able to commercially deploy greater than 1 Gbps speeds with ePMP 4600 6 GHz outdoor fixed wireless. The FCC has fully approved Cambium's ePMP 4600 and 4600L access points and Force 4625 and 4600C subscriber modules to operate commercially in the ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration (FDA)’s Medical Devices Advisory Committee has strongly recommended FDA approval of the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.

MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, and autoimmune and inflammatory conditions, today announced that it has secured $7 million in commitments in two private placement funding rounds led by a strategic investor, PharmaCyte Biotech, Inc. (Nasdaq: PMCB), a clinical-stage biotechnology company developing cellular therapies for cancer and diabetes. An additional $7 million was raised from existing MyMD shareholders participating in the offerings. The closings of the two private placements are each subject to customary closing conditions and are both expected to occur on or ...